Enhamox Viên nén bao phim

Pays: Vietnam

Langue: vietnamien

Source: BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

Achète-le

Notice patient Notice patient (PIL)
23-11-2021

Ingrédients actifs:

Amoxicilin (dưới dạng Amoxicilin trihydrate); Acid clavulanic (dưới dạng Clavulanat kali)

Disponible depuis:

LLoyd Laboratories INC.

DCI (Dénomination commune internationale):

Amoxicilin (in the form of Amoxicilin trihydrate); clavulanic Acid (in the form Clavulanat potassium)

Dosage:

500mg; 125mg

forme pharmaceutique:

Viên nén bao phim

Unités en paquet:

Hộp 1 vỉ x 10 viên; Hộp 2 vỉ x 10 viên ; Hộp 6 vỉ x 10 viên

classe:

Thuốc kê đơn

Fabriqué par:

LLoyd Laboratories INC.

Descriptif du produit:

Tiêu Chuẩn: USP 36; Tuổi Thọ: 24 tháng; Tá dược: Magnesi tartrat, natri croscarmellose, colloidal anhydrous silica, butylated hydroxytoluen, talc, cellulose vi tinh thể, ethyl cellulose, hypromethylcellulose, titan dioxid

Notice patient

                                BỌ
Y
TE
CUC
QUAN
LY
DUOC
DA
PHE
DUYET
ae
Baich
No-
9K
1002
LLOYD
LABORATORIES
ie
Màu De,
07/12/2000
ae
Ema
Ute
baci
Enhamox
Enhamox
co-amosiclay
co-amoxiclay
ee
e/a
|
Son!
ie
|
R
eames
R
pases
——
——
Enhamox
Enhamox
co-mmoxiclay
‹0-mmnoxicÙav:
JL)
em
|
wees
|—'%$^4/
1%“
Ì——'%^S/
“Gino
Fee
Comet
te
(Cet
(aon
—
—
Enhamox
Enhamox
co-amoxiclav
cu-menoxiclay
——:55Š/
ee
(eae
/
te
R
Fir
Coated
Tebiat
RK
px
.——
——
Enhamox
Enhamox
ev-amoxiclay
cưứamowirlav
ae
ca
SH,
emma
|
Omer
Rent
je
See
ey
|
tre
lam
|
Soe
TH
|
recom
Soe
R
_
(amt
pTrp7ZmZĩ"—
—~
Enhamox Enhamox
cramoxiclay
co-amoxiclav
pn
ae)
Ta
ei
|
R
=—=
KR
|=
Enhamox
Enhamox
co-amoxiclay
_.
teramoaxiclay
HH]
HH
K
p——
R
a
Enhamox
Enhamox
co-amoxiclay
co-amoziclay
—(
(S5
R—
KP
nhe
Enhamox
Enhamox
co-amoniclay
aa
co-amoxiclay
eo
ml
e/a
|
`“:
ay
R
|==~
R
=>
Enhamox
Enhamox
eo-amenicl
ay
co-ameasiclay
Came
[Comme
one}
—ˆ,—=.~
l—( 2S
B—('G^S/
`“
|
|
o>
=e
Sa
med
ed
ri
—
Enhamox
Enhamox
co-nmpxirlsu
co-amoxiclav
—
——
|—.
=a
ar
Ì——'%^4:/
no
Re
eee
R
Enhamox
Enhamox
#n-armoxirlav
co-amonxiclay
(ai
|}
ae
we
.-—_
_——-
~*~
pam
Ss)
ae
}—'
<
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit

Afficher l'historique des documents